These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists. Klawans HL; Paleologos N Clin Neuropharmacol; 1986; 9(3):298-302. PubMed ID: 3719575 [TBL] [Abstract][Full Text] [Related]
50. Lisuride in parkinsonism. Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665 [TBL] [Abstract][Full Text] [Related]
51. Dopamine agonists in the treatment of Parkinson's disease. Rinne UK Adv Neurol; 1983; 37():141-50. PubMed ID: 6305175 [TBL] [Abstract][Full Text] [Related]
52. [The treatment of Parkinson disease using the combination bromocriptine and levodopa]. Dufresne JJ Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793 [No Abstract] [Full Text] [Related]
54. Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease. Stern GM; Lees AJ Adv Neurol; 1983; 37():17-21. PubMed ID: 6858771 [TBL] [Abstract][Full Text] [Related]
55. Further experiences with low doses of bromocriptine in Parkinson's disease. Fahn S; Côté LJ; Barrett RE; Snider SR Adv Biochem Psychopharmacol; 1980; 23():255-60. PubMed ID: 7395615 [No Abstract] [Full Text] [Related]
56. Bromocriptine in the treatment of advanced breast cancer. Barrett A; Morgan L; Raggatt PR; Hobbs JR Clin Oncol; 1976 Dec; 2(4):373-7. PubMed ID: 1037393 [No Abstract] [Full Text] [Related]
57. [Experience with the use of parlodel in the treatment of Parkinson patients]. Stoliarova LG; Kadykov AS; Shvedkov VV; Pivovarova VM Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):219-22. PubMed ID: 3705825 [TBL] [Abstract][Full Text] [Related]
58. The role of bromocriptine in the treatment of Parkinson's disease. Stern GM; Lees AJ; Shaw KM; Lander CM Adv Biochem Psychopharmacol; 1980; 23():267-70. PubMed ID: 7395617 [No Abstract] [Full Text] [Related]
59. [Bromocriptine (Parlodel) in parkinsonism]. Pakkenberg H Ugeskr Laeger; 1978 May; 140(22):1297. PubMed ID: 653876 [No Abstract] [Full Text] [Related]
60. Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease. Todman DH; Oliver WA; Edwards RL Clin Exp Neurol; 1990; 27():79-82. PubMed ID: 2129961 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]